Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)
CNY 16.91
(1.74%)
CNY 16.91
(1.74%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.62 Billion CNY | -0.33% |
| 2022 | 3.63 Billion CNY | 32.4% |
| 2021 | 2.74 Billion CNY | 11.28% |
| 2020 | 2.46 Billion CNY | 20.44% |
| 2019 | 2.05 Billion CNY | -2.99% |
| 2018 | 2.11 Billion CNY | -1.79% |
| 2017 | 2.15 Billion CNY | 5.62% |
| 2016 | 2.03 Billion CNY | 10.12% |
| 2015 | 1.85 Billion CNY | 56.62% |
| 2014 | 1.18 Billion CNY | 25.44% |
| 2013 | 941.89 Million CNY | 8.99% |
| 2012 | 864.18 Million CNY | 2.4% |
| 2011 | 843.9 Million CNY | 142.05% |
| 2010 | 348.64 Million CNY | 17.09% |
| 2009 | 297.76 Million CNY | 6.39% |
| 2008 | 279.87 Million CNY | 11.39% |
| 2007 | 251.25 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 3.87 Billion CNY | -0.56% |
| 2024 Q2 | 3.89 Billion CNY | 0.76% |
| 2024 Q1 | 3.86 Billion CNY | 6.55% |
| 2023 FY | 3.62 Billion CNY | -0.33% |
| 2023 Q2 | 3.54 Billion CNY | -1.34% |
| 2023 Q1 | 3.59 Billion CNY | -1.16% |
| 2023 Q3 | 3.54 Billion CNY | -0.15% |
| 2023 Q4 | 3.62 Billion CNY | 2.36% |
| 2022 Q4 | 3.63 Billion CNY | 43.94% |
| 2022 Q2 | 2.52 Billion CNY | -0.78% |
| 2022 Q1 | 2.54 Billion CNY | -7.35% |
| 2022 FY | 3.63 Billion CNY | 32.4% |
| 2022 Q3 | 2.52 Billion CNY | 0.06% |
| 2021 Q2 | 2.68 Billion CNY | 1.13% |
| 2021 Q1 | 2.65 Billion CNY | 7.46% |
| 2021 FY | 2.74 Billion CNY | 11.28% |
| 2021 Q4 | 2.74 Billion CNY | -17.19% |
| 2021 Q3 | 3.31 Billion CNY | 23.67% |
| 2020 Q3 | 2.1 Billion CNY | 1.73% |
| 2020 Q2 | 2.07 Billion CNY | -0.53% |
| 2020 FY | 2.46 Billion CNY | 20.44% |
| 2020 Q1 | 2.08 Billion CNY | 1.55% |
| 2020 Q4 | 2.46 Billion CNY | 17.21% |
| 2019 FY | 2.05 Billion CNY | -2.99% |
| 2019 Q3 | 2.08 Billion CNY | -0.04% |
| 2019 Q1 | 2.18 Billion CNY | 3.18% |
| 2019 Q2 | 2.08 Billion CNY | -4.18% |
| 2019 Q4 | 2.05 Billion CNY | -1.84% |
| 2018 Q3 | 2.21 Billion CNY | 1.11% |
| 2018 Q2 | 2.18 Billion CNY | 2.69% |
| 2018 FY | 2.11 Billion CNY | -1.79% |
| 2018 Q1 | 2.13 Billion CNY | -1.01% |
| 2018 Q4 | 2.11 Billion CNY | -4.46% |
| 2017 Q2 | 2.08 Billion CNY | 4.08% |
| 2017 Q3 | 2.12 Billion CNY | 1.82% |
| 2017 Q4 | 2.15 Billion CNY | 1.45% |
| 2017 Q1 | 2 Billion CNY | -1.76% |
| 2017 FY | 2.15 Billion CNY | 5.62% |
| 2016 Q1 | 1.9 Billion CNY | 2.99% |
| 2016 Q4 | 2.03 Billion CNY | 1.96% |
| 2016 FY | 2.03 Billion CNY | 10.12% |
| 2016 Q3 | 1.99 Billion CNY | -1.61% |
| 2016 Q2 | 2.03 Billion CNY | 6.59% |
| 2015 Q2 | 1.62 Billion CNY | 38.66% |
| 2015 FY | 1.85 Billion CNY | 56.62% |
| 2015 Q4 | 1.85 Billion CNY | -1.39% |
| 2015 Q1 | 1.17 Billion CNY | -0.63% |
| 2015 Q3 | 1.87 Billion CNY | 15.28% |
| 2014 Q4 | 1.18 Billion CNY | 4.67% |
| 2014 FY | 1.18 Billion CNY | 25.44% |
| 2014 Q3 | 1.12 Billion CNY | 17.85% |
| 2014 Q2 | 957.82 Million CNY | 3.0% |
| 2014 Q1 | 929.88 Million CNY | -1.28% |
| 2013 Q3 | 890.93 Million CNY | 1.82% |
| 2013 Q4 | 941.89 Million CNY | 5.72% |
| 2013 FY | 941.89 Million CNY | 8.99% |
| 2013 Q1 | 860.76 Million CNY | -0.4% |
| 2013 Q2 | 874.98 Million CNY | 1.65% |
| 2012 FY | 864.18 Million CNY | 2.4% |
| 2012 Q2 | 860.61 Million CNY | 2.16% |
| 2012 Q3 | 837.9 Million CNY | -2.64% |
| 2012 Q4 | 864.18 Million CNY | 3.14% |
| 2012 Q1 | 842.38 Million CNY | -0.18% |
| 2011 Q3 | 832.16 Million CNY | 2.95% |
| 2011 FY | 843.9 Million CNY | 142.05% |
| 2011 Q4 | 843.9 Million CNY | 1.41% |
| 2011 Q1 | 775.09 Million CNY | 122.32% |
| 2011 Q2 | 808.29 Million CNY | 4.28% |
| 2010 Q2 | 321.79 Million CNY | 0.0% |
| 2010 FY | 348.64 Million CNY | 17.09% |
| 2010 Q4 | 348.64 Million CNY | 0.0% |
| 2009 FY | 297.76 Million CNY | 6.39% |
| 2008 FY | 279.87 Million CNY | 11.39% |
| 2007 FY | 251.25 Million CNY | 0.0% |